Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Application

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 15 > >>
download as CSV
download all results as CSV
EC Number Application Commentary Reference
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102diagnostics C2GnT1 might become a prognostic factor for endometrial carcinoma. Patients with C2GnT1 overexpression show significantly shorter survival, multivariable analysis also indicate that 2GnT1 overexpression is an independent prognostic factor 736221
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102diagnostics detection of core2 beta-1,6-N-acetylglucosaminyltransferase in post-digital rectal examination urine is a reliable indicator for extracapsular extension of prostate cancer. The number of GCNT1-positive cases is significantly lower in cases of organ-confined disease than in cases of extracapsular extension. GCNT1-negative tumors are a associated with significantly better prostate-specific antigen (PSA)-free survival compared with GCNT1-positive tumors. Multivariate analysis reveals that detection of GCNT1 expression is an independent risk factor for prostate-specific antigen recurrence 737091
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102diagnostics GCNT1 expression in prostate biopsy specimen is a significant and independent predictor of recurrence after radical prostatectomy, which can be used in pre-treatment decision making for the patient 735617
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102diagnostics GCNT3 might be an essential glycosylation-related molecule in colorectal cancer and epithelial ovarian cancer progression, with potential interest as a predictive biomarker of response to chemotherapy. GCNT3 high-expressing Stage III-IV EOC patients have better response to conventional treatment and clinical outcome. Clinical relevance of GCNT3 expression in epithelial ovarian cancer (EOC), role of GCNT3 as a biomarker for cancer patients, overview 760171
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102diagnostics possible role of GCNT3 gene expression as prognostic marker in colon cancer. Low CNT3 expression is a promising prognostic biomarker for colon cancer that could be used to identify early-stage colon cancer patients at high risk of relapse. The enzyme might also constitute a biomarker to monitor tumour response to chemotherapy in cancer patients 736047
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102medicine biomarker for aggressive potential of testicular germ cell tumor 704080
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102medicine C2GnT-1 may be a candidate of therapeutic target for the inhibition of infiltration of leukemia cells 675735
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102medicine clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer, clinicopathological parameters, overview 736047
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102medicine core2GnT is an extremely useful prognostic marker for prostate cancer progression 673873
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102medicine GCNT1 expression in prostate biopsy specimen is a significant and independent predictor of recurrence after radical prostatectomy, which can be used in pre-treatment decision making for the patient 735617
Results 1 - 10 of 15 > >>
download as CSV
download all results as CSV